Panagene Inc
KOSDAQ:046210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Panagene Inc's latest stock split occurred on Oct 18, 2002
The company executed a 455-for-422 stock split, meaning that for every 422 shares held, investors received 455 new shares.
The adjusted shares began trading on Oct 18, 2002. This was the only stock split in Panagene Inc's history.
Global
Stock Splits Monitor
Panagene Inc
Glance View
PANAGENE Inc. engages in the molecular diagnostics business. The company is headquartered in Daejeon, Daejeon and currently employs 71 full-time employees. The company went IPO on 2000-08-16. The firm develops selective deoxyribonucleic acid (DNA) amplification technology and detection technology which used in the drug susceptibity testing, single nucleotide sequence variation inspection, infectious diseases hospital inspection and other DNA relates diseases inspection. The Company’s customs mainly include DAKO, AdvanDx, Abbott, LSI Medience Corporation and others.
ROG
002315